To Study the Expression of S100 and Factor XIIIa as immune markers in leprosy

ABSTRACT: Background: Macrophages are critical for the lysis of bacteria in the defence against Mycobacterium leprae. However, cytokines from lymphocytes, such as interleukin 2 and gamma interferon, are also necessary for the effective killing of the organisms. In this study, S100 and factor XIIIa were assessed by Immunohistochemistry on the cutaneous lesions of 45 leprosy cases. Aim: To study the role of S100 and Factor XIIIa as immune markers in leprosy. Study design: Cross sectional study. Methods: Skin biopsies of clinically suspected leprosy were stained for histopathological examination, and Immunohistochemistry examination was carried out for S100 and factor XIIIa. Result: S100 expression was studied over macrophages and factor XIIIa on dermal dendrocytes. S100 positivity was seen in the lepromatous leprosy spectrum, while Factor XIIIa was observed in tuberculoid, with few indeterminant and histoid cases showing immunoreactivity. Conclusions: IHC markers can be used as an auxiliary technique to support histopathological diagnosis and aid in early and more specific diagnosis in early leprosy cases, assessing the host's immune status. Therefore, it can guide early initiation of treatment, modification of regimes and follow-up schedules. Keywords: Leprosy, Immunity, S100, Factor XIIIa

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-30
DOI
https://doi.org/10.5281/zenodo.13384447
Primary Topic
Leprosy Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

To Study the Expression of S100 and Factor XIIIa as immune markers in leprosy

Zenodo (CERN European Organization for Nuclear Research)
Leprosy Research and Treatment
article

To Study the Expression of S100 and Factor XIIIa as immune markers in leprosy

article en

Abstract

ABSTRACT: Background: Macrophages are critical for the lysis of bacteria in the defence against Mycobacterium leprae. However, cytokines from lymphocytes, such as interleukin 2 and gamma interferon, are also necessary for the effective killing of the organisms. In this study, S100 and factor XIIIa were assessed by Immunohistochemistry on the cutaneous lesions of 45 leprosy cases. Aim: To study the role of S100 and Factor XIIIa as immune markers in leprosy. Study design: Cross sectional study. Methods: Skin biopsies of clinically suspected leprosy were stained for histopathological examination, and Immunohistochemistry examination was carried out for S100 and factor XIIIa. Result: S100 expression was studied over macrophages and factor XIIIa on dermal dendrocytes. S100 positivity was seen in the lepromatous leprosy spectrum, while Factor XIIIa was observed in tuberculoid, with few indeterminant and histoid cases showing immunoreactivity. Conclusions: IHC markers can be used as an auxiliary technique to support histopathological diagnosis and aid in early and more specific diagnosis in early leprosy cases, assessing the host's immune status. Therefore, it can guide early initiation of treatment, modification of regimes and follow-up schedules. Keywords: Leprosy, Immunity, S100, Factor XIIIa

Zenodo (CERN European Organization for Nuclear Research)
Bharati Vidyapeeth (Deemed to be University) (IN)
Openalex Percentile: Top 50%
Leprosy Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.